Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study.

Contoli M, Rogliani P, Di Marco F, Braido F, Corsico AG, Amici CA, Piro R, Sarzani R, Lessi P, Scognamillo C, Scichilone N, Santus P; SAT Study Group.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619888128. doi: 10.1177/1753466619888128.

2.

A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management.

Micheletto C, Braido F, Contoli M, Di Marco F, Santus P.

Int J Chron Obstruct Pulmon Dis. 2019 Sep 23;14:2185-2193. doi: 10.2147/COPD.S216059. eCollection 2019.

3.

Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study.

Radovanovic D, Contoli M, Marco FD, Sotgiu G, Pelaia G, Braido F, Corsico AG, Micheletto C, Rogliani P, Scichilone N, Saderi L, Santus P, Solidoro P.

COPD. 2019 Aug;16(3-4):215-226. doi: 10.1080/15412555.2019.1659760. Epub 2019 Sep 9.

PMID:
31500459
4.

Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease.

Pavasini R, Fiorencis A, Tonet E, Gaudenzi E, Balla C, Maietti E, Biscaglia S, Papi A, Ferrari R, Contoli M, Campo G.

COPD. 2019 Aug;16(3-4):284-291. doi: 10.1080/15412555.2019.1645105. Epub 2019 Jul 29.

PMID:
31357891
5.

Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study.

Contoli M, Baraldo S, Conti V, Gnesini G, Marku B, Casolari P, Scrigner P, Morelli P, Saetta M, Spanevello A, Papi A.

Respirology. 2020 Jan;25(1):80-88. doi: 10.1111/resp.13607. Epub 2019 Jun 28.

6.

Corrigendum to "Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up" [Respir. Med. 153 (2019) 68-75].

Corsico AG, Braido F, Contoli M, Di Marco F, Rogliani P, Scognamillo C, Olivi I, Santus P, Scichilone N, Lazzaro C.

Respir Med. 2019 Nov - Dec;160:105724. doi: 10.1016/j.rmed.2019.06.009. Epub 2019 Jun 13. No abstract available.

PMID:
31202574
7.

Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up.

Corsico AG, Braido F, Contoli M, Di Marco F, Rogliani P, Scognamillo C, Olivi I, Santus P, Scichilone N, Lazzaro C.

Respir Med. 2019 Jul;153:68-75. doi: 10.1016/j.rmed.2019.05.017. Epub 2019 May 29. Erratum in: Respir Med. 2019 Jun 12;:.

PMID:
31174106
8.

Disease awareness in patients with COPD: measurement and extent.

Baiardini I, Rogliani P, Santus P, Corsico AG, Contoli M, Scichilone N, Di Marco F, Lessi P, Scognamillo C, Molinengo G, Ferri F, Patella V, Fiorentino G, Carone M, Braido F.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 17;14:1-11. doi: 10.2147/COPD.S179784. eCollection 2019.

9.

Effects of Anti-IL-5 on Virus-induced Exacerbation in Asthma. Light and Shadow.

Contoli M, Papi A.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):410-411. doi: 10.1164/rccm.201809-1684ED. No abstract available.

PMID:
30265568
10.

Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation?

Malagutti N, Di Laora A, Barbetta C, Groppo E, Tugnoli V, Sette E, Astolfi L, Beswick W, Borin M, Ciorba A, Pelucchi S, Stomeo F, Contoli M.

J Emerg Med. 2018 Nov;55(5):627-634. doi: 10.1016/j.jemermed.2018.07.007. Epub 2018 Aug 28.

PMID:
30170833
11.

Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD.

Santus P, Radovanovic D, Mascetti S, Pauletti A, Valenti V, Mantero M, Papi A, Contoli M.

Pharmacol Res. 2018 Jul;133:160-169. doi: 10.1016/j.phrs.2018.05.010. Epub 2018 May 23.

PMID:
29775687
12.

Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations.

Zhu J, Message SD, Mallia P, Kebadze T, Contoli M, Ward CK, Barnathan ES, Mascelli MA, Kon OM, Papi A, Stanciu LA, Edwards MR, Jeffery PK, Johnston SL.

J Allergy Clin Immunol. 2019 Jan;143(1):114-125.e4. doi: 10.1016/j.jaci.2018.04.003. Epub 2018 Apr 24.

13.

TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD.

Di Stefano A, Sangiorgi C, Gnemmi I, Casolari P, Brun P, Ricciardolo FLM, Contoli M, Papi A, Maniscalco P, Ruggeri P, Girbino G, Cappello F, Pavlides S, Guo Y, Chung KF, Barnes PJ, Adcock IM, Balbi B, Caramori G.

Chest. 2018 Apr;153(4):851-862. doi: 10.1016/j.chest.2017.12.017. Epub 2017 Dec 28.

14.

Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation.

Spadaro S, Grasso S, Karbing DS, Fogagnolo A, Contoli M, Bollini G, Ragazzi R, Cinnella G, Verri M, Cavallesco NG, Rees SE, Volta CA.

Anesthesiology. 2018 Mar;128(3):531-538. doi: 10.1097/ALN.0000000000002011.

PMID:
29215365
15.

Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.

Contoli M, Corsico AG, Santus P, Di Marco F, Braido F, Rogliani P, Calzetta L, Scichilone N.

COPD. 2017 Dec;14(6):641-647. doi: 10.1080/15412555.2017.1385056. Epub 2017 Nov 8. Review.

PMID:
29116901
16.

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD.

Contoli M, Pauletti A, Rossi MR, Spanevello A, Casolari P, Marcellini A, Forini G, Gnesini G, Marku B, Barnes N, Rizzi A, Curradi G, Caramori G, Morelli P, Papi A.

Eur Respir J. 2017 Oct 5;50(4). pii: 1700451. doi: 10.1183/13993003.00451-2017. Print 2017 Oct.

17.

Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial.

Pavasini R, Vieceli Dalla Sega F, Gallo F, Passarini G, Papi A, Contoli M, Campo G.

Eur Respir J. 2017 Oct 5;50(4). pii: 1701183. doi: 10.1183/13993003.01183-2017. Print 2017 Oct. No abstract available.

18.

Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence.

Baraldo S, Contoli M, Bonato M, Snijders D, Biondini D, Bazzan E, Cosio MG, Barbato A, Papi A, Saetta M.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):673-675. doi: 10.1164/rccm.201706-1249LE. No abstract available.

PMID:
28862881
19.

Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients.

Contoli M, Campo G, Pavasini R, Marchi I, Pauletti A, Balla C, Spanevello A, Ferrari R, Papi A.

Eur J Intern Med. 2018 Jan;47:82-86. doi: 10.1016/j.ejim.2017.08.016. Epub 2017 Aug 15.

PMID:
28821412
20.

Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience.

Simonazzi G, Curti A, Cervi F, Gabrielli L, Contoli M, Capretti MG, Rizzo N, Guerra B, Farina A, Lazzarotto T.

Fetal Diagn Ther. 2018;43(2):138-142. doi: 10.1159/000477168. Epub 2017 Jul 12.

PMID:
28697499
21.

Withdrawal of inhaled corticosteroids in COPD: A meta-analysis.

Calzetta L, Matera MG, Braido F, Contoli M, Corsico A, Di Marco F, Santus P, Scichilone N, Cazzola M, Rogliani P.

Pulm Pharmacol Ther. 2017 Aug;45:148-158. doi: 10.1016/j.pupt.2017.06.002. Epub 2017 Jun 9.

PMID:
28606478
22.

Update in Asthma 2016.

Beghé B, Fabbri LM, Contoli M, Papi A.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):548-557. doi: 10.1164/rccm.201702-0318UP. Review. No abstract available.

PMID:
28530112
23.

IFN-α/IFN-λ responses to respiratory viruses in paediatric asthma.

Baraldo S, Papi A, Saetta M, Contoli M.

Eur Respir J. 2017 Mar 29;49(3). pii: 1602489. doi: 10.1183/13993003.02489-2016. Print 2017 Mar. No abstract available.

24.

Asthma management in a specialist setting: Results of an Italian Respiratory Society survey.

Braido F, Baiardini I, Alleri P, Bacci E, Barbetta C, Bellocchia M, Benfante A, Blasi F, Bucca C, Busceti MT, Centanni S, Colanardi MC, Contoli M, Corsico A, D'Amato M, Di Marco F, Marco D, Ferrari M, Florio G, Fois AG, Foschino Barbaro MP, Silvia G, Girbino G, Grosso A, Latorre M, Maniscalco S, Mazza F, Mereu C, Molinengo G, Ora J, Paggiaro P, Patella V, Pelaia G, Pirina P, Proietto A, Rogliani P, Santus P, Scichilone N, Simioli F, Solidoro P, Terraneo S, Zuccon U, Canonica GW.

Pulm Pharmacol Ther. 2017 Jun;44:83-87. doi: 10.1016/j.pupt.2017.03.013. Epub 2017 Mar 21.

PMID:
28341462
25.

Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.

Di Marco F, Santus P, Scichilone N, Solidoro P, Contoli M, Braido F, Corsico AG.

Respir Med. 2017 Apr;125:49-56. doi: 10.1016/j.rmed.2017.03.001. Epub 2017 Mar 2. Review.

26.

Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.

Campo G, Vieceli Dalla Sega F, Pavasini R, Aquila G, Gallo F, Fortini F, Tonet E, Cimaglia P, Del Franco A, Pestelli G, Pecoraro A, Contoli M, Balla C, Biscaglia S, Rizzo P, Ferrari R.

Thromb Haemost. 2017 Mar 23;117(6):1208-1216. doi: 10.1160/TH16-12-0973. Epub 2017 Mar 23.

27.

The Contribution of Small-Airway Abnormalities in Chronic Obstructive Pulmonary Disease Clinical Manifestations: More than a Functional Issue.

Contoli M, Scichilone N.

Respiration. 2017;93(2):81-82. doi: 10.1159/000454957. Epub 2016 Dec 20. No abstract available.

28.

Effects of aclidinium on determinants of COPD severity: symptoms and quality of life.

Contoli M, Solidoro P, Di Marco F, Scichilone N, Corsico A, Braido F, Santus P.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 5;11:3043-3050. eCollection 2016. Review.

29.

Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis.

Pavasini R, Tavazzi G, Biscaglia S, Guerra F, Pecoraro A, Zaraket F, Gallo F, Spitaleri G, Contoli M, Ferrari R, Campo G.

Chron Respir Dis. 2017 May;14(2):117-126. doi: 10.1177/1479972316674393. Epub 2016 Dec 15. Review.

30.

Indacaterol-Glycopyrronium for COPD.

Contoli M, Morelli P, Papi A.

N Engl J Med. 2016 Sep 1;375(9):898. doi: 10.1056/NEJMc1609305. No abstract available.

PMID:
27579649
31.

Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease.

Campo G, Pavasini R, Biscaglia S, Contoli M, Ceconi C.

Eur Heart J Cardiovasc Pharmacother. 2015 Jul;1(3):205-11. doi: 10.1093/ehjcvp/pvv019. Epub 2015 Apr 6. Review.

PMID:
27533997
32.

Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history.

Campo G, Pavasini R, Barbetta C, Maietti E, Mascetti S, Biscaglia S, Zaraket F, Spitaleri G, Gallo F, Tonet E, Papi A, Ferrari R, Contoli M.

Int J Cardiol. 2016 Nov 1;222:806-812. doi: 10.1016/j.ijcard.2016.08.030. Epub 2016 Aug 4.

PMID:
27522379
33.

Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study.

Poletti D, Iannini V, Casolari P, Contoli M, Papi A, Kirkham P, Hansel TT, Chung KF, Barnes PJ, Pastore A, Pelucchi S, Adcock IM, Caramori G.

J Inflamm (Lond). 2016 Aug 4;13:26. doi: 10.1186/s12950-016-0134-3. eCollection 2016.

34.

Assessing small airway impairment in mild-to-moderate smoking asthmatic patients.

Contoli M, Bellini F, Morandi L, Forini G, Bianchi S, Gnesini G, Marku B, Rabe KF, Papi A.

Eur Respir J. 2016 Apr;47(4):1264-7. doi: 10.1183/13993003.01708-2015. Epub 2016 Feb 11. No abstract available.

35.

Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis.

Pavasini R, Biscaglia S, d'Ascenzo F, Del Franco A, Contoli M, Zaraket F, Guerra F, Ferrari R, Campo G.

COPD. 2016 Aug;13(4):509-14. doi: 10.3109/15412555.2015.1099620. Epub 2015 Dec 17. Review.

PMID:
26678708
36.

Biomarkers of oxidative-stress and inflammation in exhaled breath condensate from hospital cleaners.

Casimirri E, Stendardo M, Bonci M, Andreoli R, Bottazzi B, Leone R, Schito M, Vaccari A, Papi A, Contoli M, Corradi M, Boschetto P.

Biomarkers. 2016;21(2):115-22. doi: 10.3109/1354750X.2015.1118541. Epub 2015 Dec 9.

PMID:
26649641
37.

Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients.

Bernardi E, Pomidori L, Bassal F, Contoli M, Cogo A.

Int J Chron Obstruct Pulmon Dis. 2015 Sep 10;10:1899-906. doi: 10.2147/COPD.S88609. eCollection 2015.

38.

Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond.

Saturni S, Contoli M, Spanevello A, Papi A.

Allergy Asthma Immunol Res. 2015 Nov;7(6):525-33. doi: 10.4168/aair.2015.7.6.525. Epub 2015 Jul 7. Review.

39.

Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD.

Ngkelo A, Hoffmann RF, Durham AL, Marwick JA, Brandenburg SM, de Bruin HG, Jonker MR, Rossios C, Tsitsiou E, Caramori G, Contoli M, Casolari P, Monaco F, Andò F, Speciale G, Kilty I, Chung KF, Papi A, Lindsay MA, Ten Hacken NH, van den Berge M, Timens W, Barnes PJ, van Oosterhout AJ, Adcock IM, Kirkham PA, Heijink IH.

Am J Physiol Lung Cell Mol Physiol. 2015 Nov 15;309(10):L1112-23. doi: 10.1152/ajplung.00077.2015. Epub 2015 Aug 28.

40.

Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis.

Pavasini R, d'Ascenzo F, Campo G, Biscaglia S, Ferri A, Contoli M, Papi A, Ceconi C, Ferrari R.

Int J Cardiol. 2015 Jul 15;191:187-93. doi: 10.1016/j.ijcard.2015.05.006. Epub 2015 May 6. Review.

PMID:
25965630
41.

Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells.

Contoli M, Ito K, Padovani A, Poletti D, Marku B, Edwards MR, Stanciu LA, Gnesini G, Pastore A, Spanevello A, Morelli P, Johnston SL, Caramori G, Papi A.

Allergy. 2015 Aug;70(8):910-20. doi: 10.1111/all.12627. Epub 2015 Apr 24.

42.

Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD.

Campo G, Pavasini R, Malagù M, Punzetti S, Napoli N, Guerzoni F, Papi A, Ceconi C, Contoli M.

COPD. 2015;12(5):560-7. doi: 10.3109/15412555.2014.995293. Epub 2015 Mar 16.

PMID:
25775224
43.

Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management.

Campo G, Pavasini R, Malagù M, Mascetti S, Biscaglia S, Ceconi C, Papi A, Contoli M.

Cardiovasc Drugs Ther. 2015 Apr;29(2):147-57. doi: 10.1007/s10557-014-6569-y. Review.

PMID:
25645653
44.

Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.

Papi A, Marku B, Scichilone N, Maestrelli P, Paggiaro P, Saetta M, Nava S, Folletti I, Bertorelli G, Bertacco S, Contoli M, Plebani M, Barbaro MPF, Spanevello A, Aliani M, Pannacci M, Morelli P, Beghé B, Fabbri LM; AIFASMA Study Group.

Lancet Respir Med. 2015 Feb;3(2):109-119. doi: 10.1016/S2213-2600(14)70266-8. Epub 2014 Dec 4.

PMID:
25481378
45.

Small airway disease in asthma: pathophysiological and diagnostic considerations.

Contoli M, Santus P, Papi A.

Curr Opin Pulm Med. 2015 Jan;21(1):68-73. doi: 10.1097/MCP.0000000000000122. Review.

PMID:
25415403
46.

Bronchial thermoplasty in severe asthma: food for thoughts.

Bezzi M, Solidoro P, Patella V, Contoli M, Scichilone N.

Minerva Med. 2014 Jun;105(3 Suppl 2):7-13. Epub 2014 Jul 4.

47.

Rhinovirus-induced interferon production in asthma.

Baraldo S, Saetta M, Barbato A, Contoli M, Papi A.

Thorax. 2014 Aug;69(8):772. doi: 10.1136/thoraxjnl-2013-204922. Epub 2014 Apr 2. No abstract available.

PMID:
24695636
48.

Congenital cytomegalovirus infection and small for gestational age infants.

Simonazzi G, Curti A, Murano P, Cervi F, Contoli M, Lazzarotto T, Capretti MG, Rizzo N, Guerra B.

Prenat Diagn. 2014 Aug;34(8):765-9. doi: 10.1002/pd.4362. Epub 2014 Apr 15.

PMID:
24665022
49.

Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma.

Zhu J, Message SD, Qiu Y, Mallia P, Kebadze T, Contoli M, Ward CK, Barnathan ES, Mascelli MA, Kon OM, Papi A, Stanciu LA, Jeffery PK, Johnston SL.

Chest. 2014 Jun;145(6):1219-1229. doi: 10.1378/chest.13-1567.

50.

Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: a randomised controlled trial on the effects of sulphurous thermal water inhalation.

Contoli M, Gnesini G, Forini G, Marku B, Pauletti A, Padovani A, Casolari P, Taurino L, Ferraro A, Chicca M, Ciaccia A, Papi A, Pinamonti S.

ScientificWorldJournal. 2013 Dec 23;2013:927835. doi: 10.1155/2013/927835. eCollection 2013.

Supplemental Content

Loading ...
Support Center